156 related articles for article (PubMed ID: 37273107)
61. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.
Chiyomaru T; Yamamura S; Fukuhara S; Hidaka H; Majid S; Saini S; Arora S; Deng G; Shahryari V; Chang I; Tanaka Y; Tabatabai ZL; Enokida H; Seki N; Nakagawa M; Dahiya R
PLoS One; 2013; 8(3):e58929. PubMed ID: 23554959
[TBL] [Abstract][Full Text] [Related]
62. Widespread deregulation of microRNA expression in human prostate cancer.
Ozen M; Creighton CJ; Ozdemir M; Ittmann M
Oncogene; 2008 Mar; 27(12):1788-93. PubMed ID: 17891175
[TBL] [Abstract][Full Text] [Related]
63. miR-21: an oncomir on strike in prostate cancer.
Folini M; Gandellini P; Longoni N; Profumo V; Callari M; Pennati M; Colecchia M; Supino R; Veneroni S; Salvioni R; Valdagni R; Daidone MG; Zaffaroni N
Mol Cancer; 2010 Jan; 9():12. PubMed ID: 20092645
[TBL] [Abstract][Full Text] [Related]
64. Expression profile analysis reveals putative prostate cancer-related microRNAs.
Song H; Liu Y; Pan J; Zhao ST
Genet Mol Res; 2013 Oct; 12(4):4934-43. PubMed ID: 24301753
[TBL] [Abstract][Full Text] [Related]
65. Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs.
Erdmann K; Kaulke K; Thomae C; Huebner D; Sergon M; Froehner M; Wirth MP; Fuessel S
BMC Cancer; 2014 Feb; 14():82. PubMed ID: 24517338
[TBL] [Abstract][Full Text] [Related]
66. Determination of miRNA expression profile in patients with prostate cancer and benign prostate hyperplasia.
Sancer O; Koşar PA; Tefebaşı MY; Ergün O; Demir M; Koşar A
Turk J Med Sci; 2022 Jun; 52(3):788-795. PubMed ID: 36326314
[TBL] [Abstract][Full Text] [Related]
67. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
[TBL] [Abstract][Full Text] [Related]
68. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer.
Ambs S; Prueitt RL; Yi M; Hudson RS; Howe TM; Petrocca F; Wallace TA; Liu CG; Volinia S; Calin GA; Yfantis HG; Stephens RM; Croce CM
Cancer Res; 2008 Aug; 68(15):6162-70. PubMed ID: 18676839
[TBL] [Abstract][Full Text] [Related]
69. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.
Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O
Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391
[TBL] [Abstract][Full Text] [Related]
70. SChLAP1 promotes prostate cancer development through interacting with EZH2 to mediate promoter methylation modification of multiple miRNAs of chromosome 5 with a DNMT3a-feedback loop.
Huang K; Tang Y
Cell Death Dis; 2021 Feb; 12(2):188. PubMed ID: 33589600
[TBL] [Abstract][Full Text] [Related]
71. Triplex-forming MicroRNAs form stable complexes with HIV-1 provirus and inhibit its replication.
Kanak M; Alseiari M; Balasubramanian P; Addanki K; Aggarwal M; Noorali S; Kalsum A; Mahalingam K; Pace G; Panasik N; Bagasra O
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):532-45. PubMed ID: 20502318
[TBL] [Abstract][Full Text] [Related]
72. Identification of cell-free microRNAs in the urine of patients with prostate cancer.
Korzeniewski N; Tosev G; Pahernik S; Hadaschik B; Hohenfellner M; Duensing S
Urol Oncol; 2015 Jan; 33(1):16.e17-16.e22. PubMed ID: 25445383
[TBL] [Abstract][Full Text] [Related]
73. miR-888 is an expressed prostatic secretions-derived microRNA that promotes prostate cell growth and migration.
Lewis H; Lance R; Troyer D; Beydoun H; Hadley M; Orians J; Benzine T; Madric K; Semmes OJ; Drake R; Esquela-Kerscher A
Cell Cycle; 2014; 13(2):227-39. PubMed ID: 24200968
[TBL] [Abstract][Full Text] [Related]
74. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
75. Prioritizing cancer-related microRNAs by integrating microRNA and mRNA datasets.
Jin D; Lee H
Sci Rep; 2016 Oct; 6():35350. PubMed ID: 27734929
[TBL] [Abstract][Full Text] [Related]
76. A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer.
Stegeman S; Moya L; Selth LA; Spurdle AB; Clements JA; Batra J
Endocr Relat Cancer; 2015 Apr; 22(2):265-76. PubMed ID: 25670033
[TBL] [Abstract][Full Text] [Related]
77. MicroRNA expression profile analysis reveals diagnostic biomarker for human prostate cancer.
Liu DF; Wu JT; Wang JM; Liu QZ; Gao ZL; Liu YX
Asian Pac J Cancer Prev; 2012; 13(7):3313-7. PubMed ID: 22994753
[TBL] [Abstract][Full Text] [Related]
78. The deregulation of miR-17/CCND1 axis during neuroendocrine transdifferentiation of LNCaP prostate cancer cells.
Dankert JT; Wiesehöfer M; Czyrnik ED; Singer BB; von Ostau N; Wennemuth G
PLoS One; 2018; 13(7):e0200472. PubMed ID: 30001402
[TBL] [Abstract][Full Text] [Related]
79. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L
Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958
[TBL] [Abstract][Full Text] [Related]
80. Integrated analysis of miRNA landscape and cellular networking pathways in stage-specific prostate cancer.
Verma S; Pandey M; Shukla GC; Singh V; Gupta S
PLoS One; 2019; 14(11):e0224071. PubMed ID: 31756185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
